May 31, 2019 — Allergan recalled all textured breast implants in Canada due to the risk of a rare cancer called Anaplastic Large Cell Lymphoma (ALCL).
Textured breast implants have a rough surface, which seems to increase the risk of ALCL compared to smooth-surfaced breast implants. Lymphoma can develop months or years after the surgery.
Health Canada suspended Allergan’s licenses for all textured breast implants based on a safety review, which found a “significantly higher” risk of cancer from textured implants compared to smooth implants.
At Health Canada’s request, Allergan agreed to voluntarily recall all unused Biocell breast implants from the Canadian market.
“Because the potential risks associated with the implants outweigh their benefits, including the rare but serious risk of BIA-ALCL, Health Canada has suspended the licences for Allergan’s Biocell breast implants (the only macro-textured implants available in Canada).”
The agency found 26 reports of women in Canada who developed ALCL after receiving breast implants. All of the cases involved women with textured implants, and 85% of those women had Allergan’s Biocell textured implants. No cases were linked to smooth implants.
The estimated risk of ALCL from Allergan Biocell macro-textured breast implants is 1 in 3,565. Another type of textured breast implant, Mentor Siltex micro-textured implant, was linked to a 1 in 16,703 risk.
In December 2018, Allergan withdrew all textured breast implants from the market in Europe after French regulators ordered a recall.
In the United States, textured implants are still on the market while the FDA continues to investigate the safety risks. Earlier this year, the FDA said it has received reports 457 women with breast implants who developed ALCL since 2010, including 9 women who died and 246 new cases since 2017.
Do I have a Breast Implant Lawsuit?
The Schmidt Firm, PLLC is currently accepting breast implant induced injury cases in all 50 states. If you or somebody you know has been diagnosed with Anaplastic Large Cell Lymphoma (ALCL), you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Medical Device Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.